Voloridge Investment Management
IONS icon

Voloridge Investment Management’s Ionis Pharmaceuticals IONS Stock Holding History

Voloridge Investment Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$52M Sell
655,454
-17,404
-3% -$1.31M 0.22% 146
2026
Q1 		$50.5M Buy
672,858
+87,888
+15% +$6.94M 0.2% 142
2025
Q4 		$46.3M Sell
584,970
-218,077
-27% -$16.4M 0.16% 159
2025
Q3 		$52.5M Sell
803,047
-51,587
-6% -$2.52M 0.18% 142
2025
Q2 		$33.8M Buy
854,634
+477,430
+127% +$15.6M 0.12% 209
2025
Q1 		$11.4M Buy
377,204
+60,261
+19% +$1.97M 0.04% 527
2024
Q4 		$11.1M Sell
316,943
-63,698
-17% -$2.38M 0.04% 541
2024
Q3 		$15.2M Buy
+380,641
New +$17.7M 0.06% 452
2024
Q2 		– Sell
-191,367
Closed -$8.3M – 1289
2024
Q1 		$8.3M Sell
191,367
-72,754
-28% -$3.47M 0.03% 530
2023
Q4 		$13.4M Buy
+264,121
New +$12.7M 0.05% 407
2023
Q3 		– Sell
-5,348
Closed -$219K – 1494
2023
Q2 		$219K Buy
+5,348
New +$206K ﹤0.01% 1312
2023
Q1 		– Sell
-30,709
Closed -$1.16M – 1472
2022
Q4 		$1.16M Buy
+30,709
New +$1.29M 0.01% 1105
2022
Q2 		– Sell
-189,556
Closed -$7.02M – 1535
2022
Q1 		$7.02M Sell
189,556
-77,289
-29% -$2.53M 0.04% 518
2021
Q4 		$8.12M Buy
+266,845
New +$8.4M 0.04% 530
2020
Q4 		– Sell
-94,905
Closed -$4.5M – 1441
2020
Q3 		$4.5M Buy
+94,905
New +$5.27M 0.04% 471
2019
Q3 		– Sell
-102,063
Closed -$6.56M – 1139
2019
Q2 		$6.56M Buy
102,063
+95,907
+1,558% +$6.78M 0.18% 115
2019
Q1 		$500K Buy
+6,156
New +$397K 0.02% 670
2017
Q1 		– Sell
-83,336
Closed -$3.99M – 580
2016
Q4 		$3.99M Buy
+83,336
New +$3.3M 0.09% 293

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Voloridge Investment Management's IONS Position: Q2 2026 in Review

Voloridge Investment Management reduced its Ionis Pharmaceuticals (IONS) stake by 2.6% in Q2 2026, selling an estimated $1.31M and leaving 655,454 shares worth $52M. The position accounts for 0.22% of the portfolio, ranked #146.

Voloridge Investment Management first reported a position in IONS in Q4 2016 and has held it in 18 quarters since. The position peaked at $52.5M in Q3 2025. 515 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Voloridge Investment Management held 655,454 shares of Ionis Pharmaceuticals worth $52M as of Q2 2026.
  • Voloridge Investment Management sold 17,404 Ionis Pharmaceuticals shares in Q2 2026, an estimated $1.31M.
  • Ionis Pharmaceuticals made up 0.22% of Voloridge Investment Management's portfolio in Q2 2026, its #146 holding.
  • Voloridge Investment Management first reported a position in Ionis Pharmaceuticals in Q4 2016 and has held it in 18 quarters since.
  • Voloridge Investment Management's Ionis Pharmaceuticals position peaked at $52.5M in Q3 2025.
  • 515 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Voloridge Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.